These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39064961)

  • 21. Nucleoside dimers analogues with a 1,2,3-triazole linkage: conjugation of floxuridine and thymidine provides novel tools for cancer treatment. Part II.
    Baraniak D; Baranowski D; Ruszkowski P; Boryski J
    Nucleosides Nucleotides Nucleic Acids; 2019; 38(11):807-835. PubMed ID: 31177919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrids of MEK inhibitor and NO donor as multitarget antitumor drugs.
    Wang C; Xi D; Wang H; Niu Y; Liang L; Xu F; Peng Y; Xu P
    Eur J Med Chem; 2020 Jun; 196():112271. PubMed ID: 32305784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide donor hybrid compounds as promising anticancer agents.
    Ding QG; Zang J; Gao S; Gao Q; Duan W; Li X; Xu W; Zhang Y
    Drug Discov Ther; 2017 Jan; 10(6):276-284. PubMed ID: 27990006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
    Wang TT; Liu Y; Chen L
    Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
    Chen Z; Huang KY; Ling Y; Goto M; Duan HQ; Tong XH; Liu YL; Cheng YY; Morris-Natschke SL; Yang PC; Yang SL; Lee KH
    J Nat Prod; 2019 Nov; 82(11):3065-3073. PubMed ID: 31718182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
    Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
    Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel truncated deguelin derivative possessing nitric oxide donor as a potential anti-lung cancer agent.
    Zhou H; Dong Y; Ma X; Xu J; Xu S
    Fitoterapia; 2020 Oct; 146():104670. PubMed ID: 32540381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Investigation of the Role of Benzopyran Dihydropyrimidinone Hybrids in Cell Proliferation, Migration and Tumor Growth.
    Dash AK; Nayak D; Hussain N; Mintoo MJ; Bano S; Katoch A; Mondhe DM; Goswami A; Mukherjee D
    Anticancer Agents Med Chem; 2019; 19(2):276-288. PubMed ID: 30179143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and anticancer activity of nitric oxide donating/chalcone hybrids.
    Mourad MA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
    Eur J Med Chem; 2012 Aug; 54():907-13. PubMed ID: 22703846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Cytotoxic Properties of New Substituted Glycosides-Indole Conjugates as Apoptosis Inducers in Cancer Cells.
    Srour AM; El-Bayaa MN; Omran MM; Sharaky MM; El-Sayed WA
    Anticancer Agents Med Chem; 2021; 21(10):1323-1333. PubMed ID: 32990545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-Assembly Dual-Responsive NO Donor Nanoparticles for Effective Cancer Therapy.
    Gu G; Chen C; Zhang S; Yin B; Wang J
    ACS Appl Mater Interfaces; 2021 Nov; 13(43):50682-50694. PubMed ID: 34668695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A broad spectrum anticancer nucleoside with selective toxicity against human colon cells in vitro.
    Shelton JR; Burt SR; Peterson MA
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1484-7. PubMed ID: 21288718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
    Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
    Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel furozan-based nitric oxide-releasing derivatives of oridonin as potential anti-tumor agents.
    Li D; Wang L; Cai H; Zhang Y; Xu J
    Molecules; 2012 Jun; 17(6):7556-68. PubMed ID: 22710829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and cytotoxic activity of novel acyclic nucleoside analogues with functionality in click chemistry.
    Gładysz M; Ruszkowski P; Milecki J
    Nucleosides Nucleotides Nucleic Acids; 2018 Jan; 37(1):53-66. PubMed ID: 29336675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of a non-natural nucleoside that displays anticancer activity against solid tumors.
    Golden J; Motea E; Zhang X; Choi JS; Feng Y; Xu Y; Lee I; Berdis AJ
    ACS Chem Biol; 2013 Nov; 8(11):2452-65. PubMed ID: 23992753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anti-hepatocellular carcinoma activity of novel O
    Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
    Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review.
    Chugunova EA; Burilov AR
    Curr Top Med Chem; 2017; 17(9):986-1005. PubMed ID: 27697059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
    Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
    Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.